Kathleen Poston, MD, MS
Academic Appointments
- Assistant Professor - Med Center Line, Neurology & Neurological Sciences
- Assistant Professor - Med Center Line (By courtesy), Neurosurgery
Key Documents
Contact Information
-
Clinical Offices
Department of Neurology 300 Pasteur Dr Rm A343 MC 5235 Stanford, CA 94305 Tel Work (650) 723-2116 Fax (650) 725-7459
- Academic Offices
Alternate Contact Sandra Wong Martin Administrative Associate, Movement Disorders Center Email Tel Work 650-723-2116Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Neurology
- Parkinson Disease
- Parkinsonian Disorders
- Multiple System Atrophy
- Palsy, Progressive Supranuclear
- Essential Tremor
Honors and Awards
- Lysia Forno Award for Teaching Excellence, Stanford University (2009-2010)
Professional Education
| Fellowship: | Columbia University Medical Center NY (2008) |
| Post-Doc: | Feinstein Institute, Functional Neuroimaging (2009) |
| Residency: | UCSF, CA USA (2006) |
| Internship: | UCSF, CA USA (2003) |
| Medical Education: | Vanderbilt University School of Medicine, TN USA (2002) |
| MS: | Vanderbilt University, Bioengineering (1998) |
Scientific Focus
Current Research Interests
Dr. Postons research interests include the development, validation and application of functional and structural neuroimaging as biomarkers for the diagnosis and treatment of movement disorders. Specifically, her research focuses on using FDG PET and fMRI to understand abnormal brain networks that lead to both motor and cognitive dysfunction in patients with parkinsonism. She is also interested in the development of novel imaging analysis techniques for establishing diagnosis and monitoring disease progression in early parkinsonian disorders, such as Parkinsons disease, multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Such techniques can be used in the development and testing of novel therapeutic interventions, such as gene transfer therapy in Parkinsons disease.
Clinical Trials
Publications
- Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage. 2012; (4): 2261-70
- Network correlates of disease severity in multiple system atrophy. Neurology. 2012; (16): 1237-44
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol. 2011; (4): 309-19
- Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci. 2010; (3): 1049-56
- Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010; (2): 149-58
- FDG PET in the Evaluation of Parkinson's Disease. PET Clin. 2010; (1): 55-64
Help